Differences in ADAMTS13 activity, anti-ADAMTS13 IgG antibody, and ADAMTS13 antigen levels between patients who experienced exacerbation and no exacerbation
| . | No exacerbation (n = 61) . | Exacerbation (n = 4) . |
|---|---|---|
| Median ADAMTS13 activity (IQR), IU/dL | 50 (9.35-80) | <10 |
| Median anti-ADAMTS13 IgG antibody (IQR), % | 11 (4-40.5) | 80 (33.25-125.3) |
| Median ADAMTS13 antigen (IQR), % | 63 (37.5-97) | 2 (1-3.75) |
| . | No exacerbation (n = 61) . | Exacerbation (n = 4) . |
|---|---|---|
| Median ADAMTS13 activity (IQR), IU/dL | 50 (9.35-80) | <10 |
| Median anti-ADAMTS13 IgG antibody (IQR), % | 11 (4-40.5) | 80 (33.25-125.3) |
| Median ADAMTS13 antigen (IQR), % | 63 (37.5-97) | 2 (1-3.75) |